Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

(MedPage Today) -- A fixed-duration, three-drug regimen for chronic lymphocytic leukemia (CLL) achieved deep and durable remissions lasting for up to 7 years, according to updated results from a prospective study.
Median progression-free survival...